KMID : 0352720170410020222
|
|
Journal of Ginseng Research 2017 Volume.41 No. 2 p.222 ~ p.226
|
|
Effect of Korean Red Ginseng intake on the survival duration of human immunodeficiency virus type 1 patients
|
|
Cho Young-Keol
Kim Jung-Eun
|
|
Abstract
|
|
|
Background: Long-term ginseng intake can increase longevity in healthy individuals. Here, we examined if long-term treatment with Panax ginseng Meyer (Korean Red Ginseng, KRG) can also enhance survival duration (SD) in patients with human immunodeficiency virus type 1 (HIV-1) infection.
Methods: We retrospectively analyzed 252 HIV-1 patients diagnosed from 1986 to 2013 prior to the initiation of antiretroviral therapy. Overall, 162 patients were treated with KRG (3,947?¡¾?4,943 g) for 86?¡¾?63 mo. The effects of KRG on SD were analyzed according to the KRG intake level and the length of the follow-up period.
Results: There were significant correlations between the total amount of KRG and SD in the KRG intake group (r?=?0.64, p?0.0001) as well as between total amount of KRG and mean annual decrease in CD4+ T-cell count in all 252 patients (r?=??0.17, p?0.01). The annual decrease in CD4+ T-cell count (change in cells/¥ìL) was significantly slower in KRG-treated patients than in patients receiving no KRG (48?¡¾?40 vs. 106?¡¾?162; p?0.001). The SD (in months) was also significantly longer in the KRG group than in the no-KRG group (101?¡¾?64 vs. 59?¡¾?40, p?0.01).
Conclusion: KRG prolongs survival in HIV-1 patients, possibly by slowing the decrease in CD4+ T-cell count.
|
|
KEYWORD
|
|
annual decrease of CD4+ T cells, human immunodeficiency virus/AIDS, Korean Red Ginseng, survival duration
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|